Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
162.22
+0.90 (0.56%)
Nov 21, 2024, 10:41 AM EST - Market open

Company Description

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally.

The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.

It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.

The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions.

Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated
Quest Diagnostics logo
Country United States
Founded 1967
IPO Date Dec 17, 1996
Industry Diagnostics & Research
Sector Healthcare
Employees 48,000
CEO James Davis

Contact Details

Address:
500 Plaza Drive
Secaucus, New Jersey 07094
United States
Phone 973 520 2700
Website questdiagnostics.com

Stock Details

Ticker Symbol DGX
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001022079
CUSIP Number 74834L100
ISIN Number US74834L1008
Employer ID 16-1387862
SIC Code 8071

Key Executives

Name Position
James E. Davis Chairman, Chief Executive Officer and President
Sam A. Samad Executive Vice President and Chief Financial Officer
Catherine T. Doherty Executive Vice President of Regional Businesses
Karthik Kuppusamy Ph.D. Senior Vice President of Clinical Solutions
Michael J. Deppe Senior Vice President, Corporate Controller and Chief Accounting Officer
Murali Balakumar Senior Vice President, Chief Information and Digital Officer
Shawn C. Bevec Vice President of Investor Relations
Kristin Lee Wallace Esq. Senior Vice President and Chief Compliance Officer
Gary D. Samuels Senior Vice President and Chief Communications Officer
Cecilia K. McKenney Senior Vice President and Chief Human Resources Officer

Latest SEC Filings

Date Type Title
Oct 28, 2024 144 Filing
Oct 23, 2024 10-Q Quarterly Report
Oct 22, 2024 8-K Current Report
Aug 29, 2024 8-K Current Report
Aug 29, 2024 144 Filing
Aug 28, 2024 144 Filing
Aug 19, 2024 8-K Current Report
Aug 16, 2024 424B2 Prospectus
Aug 15, 2024 FWP Free Writing Prospectus
Aug 15, 2024 424B2 Prospectus